Related Experiment Video
Updated: Apr 20, 2026

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
The effects of palladium nanoparticles on the renal function of female Wistar rats
Luca Fontana1, Veruscka Leso1, Alessandro Marinaccio2
1a Institute of Public Health, Catholic University of the Sacred Heart , Rome , Italy .
Abstract:
A number of studies have shown that palladium nanoparticles are able to exert some adverse health effects, such as concentration-dependent cytotoxicity, induction of apoptosis and alterations of the release and expression of numerous cytokines. Nevertheless, our current knowledge of the potential toxic effects induced by exposure to these nanoparticles is far from being complete. For this reason, the present study assessed the possible renal toxicity of palladium nanoparticles by investigating urinary excretion of retinol binding protein, β(2)-microglobulin and albumin in female Wistar rats intravenously exposed to different nanoparticle concentrations (0.012, 0.12, 1.2 and 12 µg/kg) and by carrying out a morphological observation of the kidneys of treated animals. Results showed a significant increase in urinary retinol binding protein and β(2)-microglobulin levels in rats that were administered 12 µg/kg compared to controls. Moreover, an ultrastructural study of the kidneys revealed significant alterations in the proximal and distal tubular epithelium were observed, with a range of severity, in all experimental conditions. Collectively, our findings suggest that exposure to palladium nanoparticles is able to induce a significant renal tubular dysfunction, whereas it does not seem to affect kidney glomerular filtration. However, further studies are needed to confirm our results, to understand the molecular mechanisms of toxic action and to evaluate the potential adverse effects of these nanoparticles also on the glomerular section of the kidney.
Related Concept Videos
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

